Parthenon LLC’s Gilead Sciences GILD Stock Holding History

Parthenon LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,544	Closed	-$244K	–	123
2021 Q2	$244K	Buy	+3,544	New	+$237K	0.04%	113

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parthenon LLC's GILD Position: Q3 2021 in Review

Parthenon LLC sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 3,544 shares — an estimated $244K sold.

Parthenon LLC first reported a position in GILD in Q2 2021 and held it in 1 quarter. The position peaked at $244K in Q2 2021. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

Parthenon LLC reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
Parthenon LLC sold 3,544 Gilead Sciences shares in Q3 2021, an estimated $244K.
Parthenon LLC first reported a position in Gilead Sciences in Q2 2021 and held it in 1 quarter.
Parthenon LLC's Gilead Sciences position peaked at $244K in Q2 2021.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Parthenon LLC's 13F filing for Q3 2021, filed 28 Oct 2021.